Found 187 matching trials
Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia PHASE2 The purpose of this study is to compare the efficacy and safety of venetocl...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL) PHASE2 This study will help researchers collect more information about how effecti...
Show More Status
Active Not Recruiting
Location
Stanford University Medical Center (Data collection only)
Learn More & Join Trial
A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy PHASE3 Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid c...
Show More Status
Active Not Recruiting
Location
City of Hope /ID# 154105
Learn More & Join Trial
Venetoclax and Irinotecan in Relapsed/Refractory SCLC PHASE1 This study is a single-arm, open-label, multicenter phase 1/2 trial designe...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML PHASE2 This investigator-initiated, single-arm, phase II trial is aimed to evaluat...
Show More Location
Ethical Committee of the First Affiliated Hospital of Soochow University
Learn More & Join Trial
Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy PHASE2 Patients with high tumor burden, low grade follicular lymphoma that has nev...
Show More Location
Winship Cancer Institute of Emory University
Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants. PHASE1 This is a Phase I/II clinical study to determine the maximum tolerated dose...
Show More Learn More & Join Trial
Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR) PHASE2 Open-label phase II, single arm, multicenter study with safety run-in to ev...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia PHASE2 This prospective, multi-center, randomized, controlled Phase II study is to...
Show More Location
The First Affliated Hospital of Soochow University
Learn More & Join Trial
Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia PHASE2 This study is to investigate the therapeutic efficacy and side effect of ve...
Show More Location
The First Affliated Hospital of Soochow University
Learn More & Join Trial